October 5, 2024
Headlines

July 2024

Cardurion Pharmaceuticals Secures $260 Million Series B to Advance Cardiovascular Drug Pipeline

Editor04 mins

Cardurion Pharmaceuticals, a pioneering biotechnology firm specializing in innovative therapies for cardiovascular diseases, has announced the successful completion of a $260 million Series B financing round. Led by Ascenta Capital and supported by a consortium of esteemed investors including NEA, GV, and Fidelity Management & Research Company, this substantial funding underscores Cardurion’s commitment to advancing…

Read More

Bioniq Secures $15 Million Series B to Revolutionize Personalized Supplements Market

Editor04 mins

Bioniq, a trailblazer in AI-driven personalized supplements tailored to individual health needs, has successfully closed a $15 million Series B funding round. Led by prominent European VCs HV Capital and Unbound, this funding underscores Bioniq’s commitment to disrupting the one-size-fits-all approach prevalent in the dietary supplements industry. The company, valued at $75 million post-funding, plans…

Read More

Exa Secures $22 Million to Pioneer AI-Optimized Search Technology

Editor05 mins

Exa, a pioneering AI research lab focused on revolutionizing search capabilities for artificial intelligence, has secured $22 million in seed and Series A funding led by Lightspeed Venture Partners. This investment round also saw participation from NVentures, NVIDIA’s venture capital arm, and Y Combinator, underscoring confidence in Exa’s vision to establish itself as the foundational…

Read More

Infinitum Secures $35 Million Series E Extension to Fuel Accelerated Growth and Decarbonization Efforts

Editor04 mins

Infinitum, a trailblazer in sustainable technology with its innovative air-core motor systems, has announced a significant boost to its Series E funding with an additional $35 million investment. This extension, led by Marunouchi Innovation Partners and Rice Investment Group, brings the total Series E funding to $220 million. The funding infusion aims to propel Infinitum’s…

Read More

Eye Floater Breakthrough! PulseMedica Secures $12 Million CAD to Advance Imaging and Treatment Technology

Editor23 mins

Good news for anyone experiencing those pesky eye floaters! PulseMedica, a rising star in the life sciences field, has secured $12 million CAD in funding to revolutionize how we diagnose and treat these vision disruptions. This investment fuels the development of their innovative platform, offering a beacon of hope for millions who struggle with these…

Read More

AI Injects Precision into Pharma Manufacturing: Modicus Prime Secures $3.5 Million

Editor03 mins

Good news for the pharmaceutical industry! Modicus Prime, a Texas-based innovator, has secured $3.5 million in Series A funding to revolutionize drug manufacturing with their AI-powered quality control solution, mpVision. This investment, led by Silverton Partners, empowers Modicus Prime to tackle a persistent challenge – ensuring consistent quality and eliminating costly errors during production. Traditionally,…

Read More

Alvys Secures $20.5 Million to Streamline Logistics and Supply Chains

Editor03 mins

Alvys, a next-generation logistics platform aiming to revolutionize supply chain management, has secured $20.5 million in a Series A funding round. This investment, led by Titanium Ventures with participation from Picus Capital and existing investors RTP and Bonfire, fuels Alvys’ mission to become the go-to platform for logistics and supply chain operations. The funding windfall…

Read More

Velentium Powers Up for Growth with $15 Million Injection from Trinity Capital

Editor03 mins

Velentium, a Houston-based engineering leader in medical device design and manufacturing, has secured a significant $15 million investment from Trinity Capital Inc. This strategic partnership fuels Velentium’s mission to deliver innovative and life-saving medical technologies. Velentium’s expertise spans across the entire medical device lifecycle, from concept to production. Their team offers a unique blend of…

Read More

Neuspera Medical Secures $23 Million to Advance Minimally Invasive Treatment for Overactive Bladder

Editor04 mins

Neuspera Medical, a company pioneering a discreet and minimally invasive treatment for overactive bladder (OAB), has secured $23 million in Series D financing. This significant investment round, led by Vertex Ventures HC and Treo Ventures, will propel Neuspera’s Neuspera System through U.S. Food and Drug Administration (FDA) premarket approval (PMA) and towards commercialization. OAB, a…

Read More

NanoPass Technologies Secures $4 Million Investment to Revolutionize Intradermal Delivery

Editor04 mins

Nanopass Technologies, a pioneer in intradermal delivery solutions, has secured a significant $4 million investment from lead investor Awz Ventures, as part of a $6 million funding round. This marks a major milestone for NanoPass, solidifying their position as a frontrunner in the development of safe, precise, and efficient drug delivery methods. The investment fuels…

Read More